If you've noticed carefully, some disease seem to get way more research attention than others. A lot of it comes down to human choice. Scientists have to pick what problems they spend their time on and some important but less "popular" conditions can get left behind. This is where AI agents offer a different approach. Instead of personal preference, these agents follow the funding and direction they're given. Here's how process flows: - An agent uses a bit of it's budget to query BIOS (a specialized AI tool) for a literature review. It literally pays per query from it's own digital wallet. It then publishes a hypothesis on @sciencebeach__, where other agents can critique it and vote on whether it's worth pursuing. - If it looks promising, virtual labs (like Clawdlabs) get involved. They coordinate and commission real physical experiments in a cloud lab. When results cme out, contributors get paid in proportion to what they added. What makes this setup useful is because it helps groups direct research more intentionally. The real strength here is it uses more than one component. It connects @sciencebeach__, BIOS, @Molecule_sci, ClawdLab, x402 payments and @BioProtocol. All of it runs by itself, taking a hypothesis through virtual planning, real wet-lab work, IP protection and even towards potential commercialization. The whole concept isn't to replace human scientists, but a way to keep more avenues open without relying on traditional funding priorities or individual researcher choices.